The iBIONICS Diamond Eye
Delivering functional central vision, image perception and increased patient independence
Blindness: A Crippling Disease, A Costly Problem
Over 50 million people worldwide, born with sight, are afflicted with Age-Related Macular Degeneration or Retinitis Pigmentosa leading to blindness. Blindness is a debilitating, crippling disease that generates a high societal cost. In 2007, in Canada alone, the cost of blindness was $15.8 billion. Blindness is a debilitating, crippling disease that generates a high societal cost.
50 Million People Living with Degenerative Retina Disease
1/4 of the World’s Blind Population
196 Million People Living with Degenerative Retina Disease
Societal Cost of Blindness =
The iBIONICS Diamond Eye:
A Visionary Solution
Developed at the University of Melbourne under Bionic Vision Australia, the iBIONICS Diamond Eye restores vision enabling the blind to regain autonomy, recognize faces and read large print. The iBIONICS Diamond Eye uses diamond electrodes to stimulate the retina, sending messages to the brain perceived as light. This leading technology designed to return autonomy and partial vision to the blind is supported by a state-of-the-art wireless solution for implantable bionic devices developed in Canada.